Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Non-Current Debt (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Non-Current Debt for 17 consecutive years, with $42.8 billion as the latest value for Q4 2025.

  • Quarterly Non-Current Debt fell 9.98% to $42.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $42.8 billion through Dec 2025, down 9.98% year-over-year, with the annual reading at $42.8 billion for FY2025, 9.98% down from the prior year.
  • Non-Current Debt for Q4 2025 was $42.8 billion at Bristol Myers Squibb, down from $44.5 billion in the prior quarter.
  • The five-year high for Non-Current Debt was $49.5 billion in Q1 2024, with the low at $32.1 billion in Q3 2023.
  • Average Non-Current Debt over 5 years is $41.2 billion, with a median of $41.1 billion recorded in 2021.
  • The sharpest move saw Non-Current Debt fell 18.06% in 2021, then soared 51.46% in 2024.
  • Over 5 years, Non-Current Debt stood at $39.6 billion in 2021, then dropped by 11.49% to $35.1 billion in 2022, then increased by 4.56% to $36.7 billion in 2023, then rose by 29.87% to $47.6 billion in 2024, then decreased by 9.98% to $42.8 billion in 2025.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $42.8 billion, $44.5 billion, and $44.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.